0001367644-24-000186.txt : 20241114 0001367644-24-000186.hdr.sgml : 20241114 20241114161857 ACCESSION NUMBER: 0001367644-24-000186 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241112 FILED AS OF DATE: 20241114 DATE AS OF CHANGE: 20241114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeGolyer Donald W CENTRAL INDEX KEY: 0001583098 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 241462705 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR. STE. 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 PROFESSIONAL DR CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 300 PROFESSIONAL DR CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 wk-form4_1731619131.xml FORM 4 X0508 4 2024-11-12 0 0001367644 Emergent BioSolutions Inc. EBS 0001583098 DeGolyer Donald W 300 PROFESSIONAL DR GAITHERSBURG MD 20879 1 0 0 0 0 Common Stock 2024-11-12 2024-11-12 4 S 0 25000 10.91 D 111100 D On November 12, 2024, Mr. DeGolyer sold an aggregate of 25,000 shares of Emergent BioSolutions Inc. common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $10.83 - $11.05. The Company maintains a record of the transactions and copies will be provided upon request. /s/ Richard S. Lindahl, Attorney-in-fact 2024-11-14